|
Volumn 111, Issue 2 Suppl 1, 2011, Pages
|
Clinical efficacy of GLP-1 agonists and their place in the diabetes treatment algorithm.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDIABETIC AGENT;
DIPEPTIDYL PEPTIDASE IV INHIBITOR;
GLUCAGON LIKE PEPTIDE 1;
INCRETIN;
ALGORITHM;
ARTICLE;
DRUG COMBINATION;
DRUG POTENTIATION;
HUMAN;
NON INSULIN DEPENDENT DIABETES MELLITUS;
ORAL DRUG ADMINISTRATION;
OSTEOPATHIC MEDICINE;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ALGORITHMS;
DIABETES MELLITUS, TYPE 2;
DIPEPTIDYL-PEPTIDASE IV INHIBITORS;
DRUG THERAPY, COMBINATION;
GLUCAGON-LIKE PEPTIDE 1;
HUMANS;
HYPOGLYCEMIC AGENTS;
INCRETINS;
OSTEOPATHIC PHYSICIANS;
TREATMENT OUTCOME;
|
EID: 79958265794
PISSN: None
EISSN: 19451997
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (0)
|